What is the Bio-Rad Laboratories, Inc. stock price forecast?

Bio-Rad Laboratories, Inc. is currently trading at $304.15. View real-time AI analysis on Alpha Lenz.

What is Bio-Rad Laboratories, Inc. insider trading activity?

View the latest insider trading data for Bio-Rad Laboratories, Inc. on Alpha Lenz.

What is Bio-Rad Laboratories, Inc.'s P/E ratio?

Bio-Rad Laboratories, Inc.'s P/E ratio is 10.9.

Bio-Rad Laboratories, Inc.

NYSE · BIO.B

$304.15+0.00(+0.00%)Pre-market

Ask about Bio-Rad Laboratories, Inc.'s future dividend policy...

Alpha Chat Insight

“Bio-Rad Laboratories, Inc. trades at a P/E of 10.9 (undervalued) with solid ROE of 10.8%.”

Ask for details →

Company Overview

Bio-Rad Laboratories, Inc. is a leading developer and manufacturer of advanced analytical and diagnostic technologies, playing a pivotal role in the life sciences and clinical diagnostics sectors. With a history dating back to 1952, Bio-Rad specializes in creating innovative products that develop precise and reliable solutions for laboratories worldwide. The company provides tools and systems that are instrumental in a wide range of applications, including genomics, proteomics, and food safety, thereby serving industries such as healthcare, research institutions, and quality testing. Bio-Rad's offerings include PCR instruments, chromatography systems, and immunoassays, supporting both research and clinical diagnostic processes. The company’s commitment to pioneering reliable scientific advancements has firmly positioned it in the global market as a trusted partner in scientific exploration and healthcare enhancement.

CEOMr. Norman D. Schwartz

Websitehttps://www.bio-rad.com

SectorHealthcare

IndustryMedical Devices

Employees7,700

Company Statistics

FY 2025

Profile

$8.29BMarket Cap

$2.58BRevenue

0.00Shares Out

7,700Employees

Margins

51.87%Gross

18.61%EBITDA

8.46%Operating

38.54%Pre-Tax

29.42%Net

Valuation

10.91P/E

1.11P/B

3.21EV/Sales

19.03EV/EBITDA

22.14P/FCF

Growth (CAGR)

-2.68%Rev 3Yr

0.29%Rev 5Yr

-22.80%Op Inc 3Yr

-12.30%Op Inc 5Yr

N/ANet Inc 3Yr

-27.58%Net Inc 5Yr

Returns

7.62%ROA

10.84%ROE

10.48%ROIC

Financial Health

$529.80MCash & Cash Equivalents

$2.59BNet Debt

41.90%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Bio-Rad Laboratories, Inc. trades at a P/E of 10.9 (undervalued) with solid ROE of 10.8%.”

Ask for details →

Frequently Asked Questions

Bio-Rad Laboratories, Inc. (ticker: BIO.B) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 7,700 employees. Market cap is $8.3B.

The current price is $304.15 with a P/E ratio of 10.91x and P/B of 1.11x.

ROE is 10.84% and operating margin is 8.46%. Annual revenue is $2.6B.